A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network (http://bit.ly/arndailyr) and Equity Briefing:
Ladenburg Thalmann raised its price target on shares of AMAG Pharmaceuticals, Inc. AMAG from $15.00 to $17.50. They have a buy rating on the stock.
Nomura reiterated its neutral rating on shares of ARM Holdings plc ARMH.
Goldman Sachs downgraded shares of Canon ADR CAJ from a buy rating to a neutral rating.
BMO Capital Markets initiated coverage on shares of Caterpillar Inc. CAT. They issued a market perform rating on the stock.
Wells Fargo & Co. downgraded shares of Cash America CSH from an outperform rating to a market perform rating.
BMO Capital Markets downgraded shares of Joy Global Inc. JOY from an outperform rating to an underperform rating.
UBS AG reiterated its buy rating on shares of Lam Research Co. LRCX.
BMO Capital Markets initiated coverage on shares of The Middleby Corporation MIDD. They issued a market perform rating on the stock.
Credit Suisse upgraded shares of Magellan Midstream MMP from a neutral rating to an outperform rating.
Credit Suisse lowered its price target on shares of ArcelorMittal ADR MT to $21.00.
ISI Group upgraded shares of Meritage Homes Co. MTH from a sell rating to a hold rating.
BMO Capital Markets initiated coverage on shares of Navistar NAV. They issued an underperform rating on the stock.
Standpoint Research downgraded shares of National-Oilwell Varco, Inc. NOV from a buy rating to a hold rating.
Sterne Agee initiated coverage on shares of Prospect Global Resources Inc PGRX. They issued a buy rating on the stock and set a $5.00 price target.
BMO Capital Markets initiated coverage on shares of Parker-Hannifin Co. PH. They issued a market perform rating on the stock.
Zacks reiterated its neutral rating on shares of Rockwell Automation Inc ROK. They have a $66.00 price target on the stock.
BMO Capital Markets initiated coverage on shares of Terex Co. TEX. They issued an outperform rating on the stock.
Nomura reiterated its buy rating on shares of Varian Medical Systems VAR.
Stay on top of analysts' coverage with Analyst Ratings Network's free daily email newsletter that provides a concise list of analysts' upgrades, downgrades and initiations. Register at http://bit.ly/arndailyr
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Equity Briefing via Thomson Reuters ONE
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.